Mitolactol

This classification denotes a radiosensitizing agent and epoxide compound with the molecular formula C6H12Br2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LJ2P1SIK8Y, chemically known as 1,6-dideoy-1,6-dibromo-d-mannitol but more generally known as mitolactol, which bears US NIH Compound Identifier 4208. European Medicines Agency schedules Mitolactol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09005MIG. The term MITOLACTOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). MITOLACTOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule mitolactol under HS 29055999 and SITC 51229. As of Q4 2014, MITOLACTOL remains US FDA's Preferred Term for this commodity. Mitolactol bears US NLM identifiers UMLS ID C0026252 and NCI Concept Code C662. SMILES: BRCC(O)C(O)C(O)C(O)CBR.